0001104659-24-063919.txt : 20240521
0001104659-24-063919.hdr.sgml : 20240521
20240521172902
ACCESSION NUMBER: 0001104659-24-063919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240517
FILED AS OF DATE: 20240521
DATE AS OF CHANGE: 20240521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amin Naseem
CENTRAL INDEX KEY: 0001646754
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 24970871
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD, SUITE 301
CITY: HAMPTON
STATE: NJ
ZIP: 08827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
tm2415004-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-17
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001646754
Amin Naseem
C/O AVADEL PHARMACEUTICALS PLC
10 EARLSFORT TERRACE
DUBLIN 2
L2
D02 T380
IRELAND
1
0
0
0
0
Stock Option (Right to Buy)
15.94
2024-05-17
4
A
0
49500
0
A
2034-05-17
Ordinary Shares
49500
49500
D
The options become exercisable in three equal annual installments on each of the first three anniversaries following the 5/17/2024 grant date, subject to the Reporting Person's continued service at each such vesting date.
/s/ Jerad G. Seurer, as Attorney-in-Fact
2024-05-21